As of 2025-02-19, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (42.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -210.7%.
The range of the Relative Valuation is (34.69) - (47.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 21.1x - 34.1x | 27.6x |
Forward P/E multiples | 19.0x - 28.8x | 23.9x |
Fair Price | (34.69) - (47.34) | (42.30) |
Upside | -190.8% - -223.9% | -210.7% |
Date | P/E |